Check our
Open Access Repository.
2023
78 publication(s):Note: when necessary, only the first 10 authors are displayed.Articles
- 61 -
-
Allogeneic transplantation in advanced cutaneous T-cell lymphomas (CUTALLO): a propensity score matched controlled prospective study
- Adèle de Masson, Marie Beylot-Barry, Caroline Ram-Wolff, Jean-Baptiste Mear, Stéphane Dalle, Michel d'Incan, Saskia Ingen-Housz-Oro, Corentin Orvain, Julie Abraham, Olivier Dereure et al.
- The Lancet, 2023, 401 (10392), pp.1941-1950.
- DOI : https://doi.org/10.1016/S0140-6736(23)00329-X
- Pubmed : 37105210
-
-
- 62 -
-
Anti-CD20 therapies in multiple sclerosis: From pathology to the clinic
- Jérôme de Sèze, Elisabeth Maillart, Antoine Gueguen, David A. A. Laplaud, Laure Michel, Eric Thouvenot, Helene Zephir, Luc Zimmer, Damien Biotti, Roland Liblau et al.
- Frontiers in Immunology, 2023, 14, pp.1004795.
- DOI : https://doi.org/10.3389/fimmu.2023.1004795
- Pubmed : 37033984
-
-
Other publication
- 63 -
-
Core enhancers of the 3’RR optimize IgH nuclear position and loop conformation for oriented CSR
- Charlotte Bruzeau, Justine Pollet, Morgane Thomas, Zhaoqing Ba, David Roulois, Eric Pinaud, Sandrine Le Noir
- 2023.
- DOI : https://doi.org/10.1101/2023.07.11.548507
-
-
Workshop/conference papers
- 64 -
-
Final analysis of the phase IB part of the LOC-R01 trial, a non-comparative randomized phase IB/II study of escalating doses of lenalidomide and ibrutinib in association with R-MPV for patients with a newly diagnosed primary central nervous system lymphoma (PCNSL)
- Marion Alcantara, M. Chevrier, Fabrice Jardin, Anna Schmitt, Caroline Houillier, Lucie Oberic, Olivier L. Chinot, Franck Morschhauser, Frederic Peyrade, Roch Houot et al.
- 2023 ASCO Annual Meeting, Jun 2023, Chicago, United States. pp.7566-7566,
- DOI : https://doi.org/10.1200/JCO.2023.41.16_suppl.7566
-
-
- 65 -
-
Single-Cell Longitudinal Characterization of FL Heterogeneity and Residual Disease in the Bone Marrow from Low-Tumor Burden FL Enrolled in the Flirt Clinical Trial
- Alicia Beyou, Simon Leonard, Ilenia Papa, Noushin Mossadegh-Keller, Sabrina Baaklini, Lionel Spinelli, Owen Hoare, Bertrand Nadel, Pierre Milpied, Joëlle Dulong et al.
- 65th ASH Annual Meeting, Dec 2023, San Diego, United States. pp.852,
- DOI : https://doi.org/10.1182/blood-2023-186070
-
-
- 66 -
-
Invasive Fungal Infections after CAR T-Cell Therapy for B-Cell Lymphoma: A Study from the French Descart Registry
- Amélie Bouvier, Amandine Durand, Nicolas Gower, Cristina Castilla-Llorente, Arnaud Campidelli, Rémy Duléry, Jean-Pierre Gangneux, Magalie Joris, Martin Eloit, Amandine Fayard et al.
- 65th ASH Annual Meeting, Dec 2023, San Diego, United States. pp.2140,
- DOI : https://doi.org/10.1182/blood-2023-185632
-
-
- 67 -
-
Real World Data of Axicabtagene Ciloleucel As Second Line Therapy for Patients with Large B Cell Lymphoma: First Results of a Lysa Study from the French Descar-T Registry
- Gabriel Brisou, Guillaume Cartron, Emmanuel Bachy, Catherine Thieblemont, Cristina Castilla-Llorente, Fabien Le Bras, François-Xavier Gros, Michael Loschi, Roch Houot, Rémy Duléry et al.
- 65th ASH Annual Meeting, Dec 2023, San Diego, United States. pp.5138,
- DOI : https://doi.org/10.1182/blood-2023-180241
-
-
- 68 -
-
Is CAR T a Drug or a Therapeutic Pathway? Systematic Review, (Re-)Estimation of Efficacy Endpoints and Metanalyses in Large B-Cell Lymphoma Real World Reports
- Pier Luigi Zinzani, Rossana Di Staso, Beatrice Casadei, Frederick Locke, Michael D. Jain, Timothy Voorhees, Adam S Kittai, Mariana Bastos-Oreiro, Antonio Gutiérrez, Alejandro Martin Garcia-Sancho et al.
- 65th ASH Annual Meeting, Dec 2023, San Diego, United States. pp.6938,
- DOI : https://doi.org/10.1182/blood-2023-178526
-
-
- 69 -
-
CSF-related metabolic switch with specific clonal amplification of pathogenic T and B cell subsets in early MS patients
- Marion Mandon, Leonard Simon, Monvoisin Celine, Jean Rachel Barroga, Emmanuelle Le Page, Gilles Edan, Tarte Karin, Ame Patricia, Delaloy Celine, S Rodriguez et al.
- 9th Joint ECTRIMS-ACTRIMS meeting, Oct 2023, Milan, Italy.
-
-
- 70 -
-
Impact of Paraclinical Investigations in the Management of CAR T-Cell-Associated Neurotoxicity: Lessons Learned from Real World Experience
- Matteo Mauget, Guillaume Manson, Roch Houot
- 65th ASH Annual Meeting, Dec 2023, San Diego, United States. pp.4881,
- DOI : https://doi.org/10.1182/blood-2023-180199
-
-